Get the Stockscreener App
66.96
2.87%
-1.98
After Hours:
66.95
-0.010
-0.01%
Dexcom Inc stock is traded at $66.96, with a volume of 6.85M.
It is down -2.87% in the last 24 hours and up +12.33% over the past month.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$68.94
Open:
$69.025
24h Volume:
6.85M
Relative Volume:
1.06
Market Cap:
$26.12B
Revenue:
$4.30B
Net Income/Loss:
$571.50M
P/E Ratio:
46.87
EPS:
1.4285
Net Cash Flow:
$570.80M
1W Performance:
+2.24%
1M Performance:
+12.33%
6M Performance:
-19.18%
1Y Performance:
-15.17%
1-Day Range:
$66.67
$69.31
1-Week Range:
$64.00
$69.77
52-Week Range:
$54.11
$93.25
Dexcom Inc Stock (DXCM) Company Profile
Name
Dexcom Inc
Sector
Industry
Phone
(858) 200-0200
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
66.96 | 26.89B | 4.30B | 571.50M | 570.80M | 1.4285 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-25-25 | Initiated | Evercore ISI | In-line |
| Oct-21-25 | Resumed | Stifel | Buy |
| Sep-08-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-21-25 | Initiated | Argus | Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| May-30-25 | Initiated | Goldman | Buy |
| Apr-10-25 | Initiated | Mizuho | Outperform |
| Feb-03-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jan-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-26-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-24 | Initiated | Redburn Atlantic | Neutral |
| Mar-12-24 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-17-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Jan-26-23 | Initiated | Wolfe Research | Outperform |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-15-22 | Initiated | Bernstein | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-07-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-18-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-28-21 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Jan-06-21 | Upgrade | UBS | Neutral → Buy |
| Oct-02-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| May-27-20 | Reiterated | Piper Sandler | Overweight |
| May-14-20 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Nov-07-19 | Reiterated | Canaccord Genuity | Buy |
| Nov-07-19 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-23-19 | Initiated | Stifel | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-19-18 | Upgrade | Goldman | Sell → Neutral |
| Sep-12-18 | Upgrade | Northland Capital | Under Perform → Market Perform |
| Aug-02-18 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-08-18 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-18 | Initiated | BofA/Merrill | Buy |
| May-03-18 | Reiterated | Canaccord Genuity | Buy |
| Apr-04-18 | Initiated | Goldman | Sell |
| Apr-04-18 | Initiated | Guggenheim | Neutral |
| Mar-23-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-04-18 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-28-17 | Reiterated | Wedbush | Outperform |
View All
Dexcom Inc Stock (DXCM) Latest News
DXCM DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 29 Deadline in Securities Class Action – DXCM - GlobeNewswire Inc.
Jim Cramer on DexCom: "It's Too Rich a Stock" - Finviz
Jim Cramer on DexCom: “It’s too rich a stock” - MSN
Jim Cramer on DexCom: “It’s Too Rich a Stock” - Yahoo Finance UK
Bellevue Group AG Cuts Holdings in DexCom, Inc. $DXCM - MarketBeat
Shareholders of DexCom, Inc. Should Contact Levi & - GlobeNewswire
Key facts: DexCom faces class action lawsuit; Citigroup raises price target - TradingView — Track All Markets
DexCom, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit - Business Wire
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
Citigroup Maintains DexCom (DXCM) Buy Recommendation - Nasdaq
DexCom Stock Surges 12%, With A 11-Day Winning Spree - Trefis
DexCom (DXCM) Sees Buy Rating Maintained by Citigroup with Price - GuruFocus
Your Guide to the DexCom, Inc. LawsuitA SueWallSt Podcast From Levi & Korsinsky - ACCESS Newswire
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class ActionContact Lieff Cabraser - ACCESS Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. LawsuitDXCM - PR Newswire
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus
Citigroup Adjusts DexCom Price Target to $77 From $75, Maintains Buy Rating - marketscreener.com
Frontier Capital Management Co. LLC Sells 35,907 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom Stock 10-Day Winning Spree: Stock Climbs 9.5% - Trefis
DXCM Deadline: DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - Morningstar
Levi & Korsinsky Releases SueWallSt Podcast on DexCom, Inc. (DXCM) Lawsuit - ACCESS Newswire
Sirios Capital Management L P Boosts Stock Position in DexCom, Inc. $DXCM - MarketBeat
Natixis Has $5.47 Million Holdings in DexCom, Inc. $DXCM - MarketBeat
DexCom Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
DexCom, Inc. (DXCM) Shareholders Get Answers in Latest SueWallSt Podcast - ACCESS Newswire
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bank of Nova Scotia Sells 400,824 Shares of DexCom, Inc. $DXCM - Defense World
2Xideas AG Sells 27,564 Shares of DexCom, Inc. $DXCM - MarketBeat
8-Day Rally Sends DexCom Stock Up 6.4% - Trefis
Shareholders that lost money on DexCom, Inc.(DXCM) Urged to - GlobeNewswire
DEXCOM, INC. (NASDAQ: DXCM) SHAREHOLDER ALERT Bernstein - GlobeNewswire
DexCom, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before December 26, 2025 to Discuss Your RightsDXCM - PR Newswire
DexCom, Inc. $DXCM Shares Acquired by WINTON GROUP Ltd - MarketBeat
DexCom, Inc. $DXCM Holdings Decreased by Brown Advisory Inc. - Defense World
Lost Money on DexCom, Inc. (DXCM)? Contact Levi & Korsinsky to Join Class Action Before December 26, 2025 - Stockhouse
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
First Trust Advisors LP Has $74.25 Million Position in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Acquired by Arrowstreet Capital Limited Partnership - MarketBeat
DXCM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages - GlobeNewswire
Guggenheim Capital LLC Grows Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Northwestern Mutual Wealth Management Co. Sells 53,670 Shares of DexCom, Inc. $DXCM - MarketBeat
Is DexCom Stock Underperforming the S&P 500? - MSN
DXCM SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc. (DXCM) - PR Newswire
Shareholders SueWallSt in New Class Action Against DexCom, Inc.Act Now - Nasdaq
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Lowey Dannenberg Notifies DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm - GlobeNewswire
SueWallSt Podcast Series Launches With Focus on DexCom, Inc. (DXCM) Fraud Allegations - ACCESS Newswire
Dexcom Inc Stock (DXCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):